Search results
27 wrz 2024 · This study aims to retrospectively investigate the use of a cyclophosphamide, lomustine, vincristine, and prednisone protocol (CLOP) treatment in dogs with naïve T-cell lymphoma patients and identify prognostic factors.
Lomustine (CCNU), an oral alkylating agent, was evaluated in 43 dogs with relapsed lymphoma or lymphoma that did not go into complete remission (CR). The dogs were treated with 90–100 mg/m 2 PO q 3 weeks and showed a durable response with 3 CR, 8 PR (partial remission) for a median of 86 days.
11 maj 2023 · Canine lymphoma is a common cancer of one of the white blood cells that is commonly treated with chemotherapy. Many papers have been published about this disease and treatment, but few comprehensive reviews of the outcomes reported after chemotherapy, and the prognostic factors that influence the outcomes, have been published.
Lymphoma in dogs is often diagnosed through a combination of findings on physical examination and cytologic evaluation of fine-needle aspirates of enlarged lymph nodes. Most dogs with lymphoma respond positively to systemic chemotherapy, with improved quality of life and overall survival time.
12 sty 2024 · This article discusses the three most commonly employed diagnostic tests when a definitive cytologic diagnosis of canine lymphoma cannot be reached, 1) histopathologic evaluation, 2) immunophenotyping, and 3) PCR for antigen receptor rearrangement (PARR).
Malignant lymphoma is a common cancer in dogs. It is a progressive, deadly disease caused by the harmful growth of lymphocytes. Lymphoma most commonly arises from lymphoid tissues in the bone marrow, thymus, lymph nodes, or spleen. Other common sites include the skin, eye, central nervous system, and bone. Although it is common, the causes and ...
Firstly, to discover suitable and measurable biomarker tests for canine lymphoma. Secondly, to refine a testing system using mathematical models capable of quantifying and monitoring disease progress in dogs diagnosed with lymphoma.
